TSE:7774Biotechs
Japan Tissue Engineering (TSE:7774) Q3 Loss Deepens To ¥185 Million Challenging Gradual Improvement Narrative
Japan Tissue Engineering (TSE:7774) posts deeper losses in FY 2026 Q3
Japan Tissue Engineering (TSE:7774) has put out its FY 2026 third quarter scorecard, reporting revenue of ¥511.6 million and a net loss of ¥185.2 million. This translated to EPS of ¥4.56 in the red, with the share price around ¥553.0. The company has reported quarterly revenue between ¥426.4 million and ¥748.6 million over the past six periods, while EPS has ranged from a profit of ¥2.34 to losses of ¥5.97 and ¥4.56. This...